References
- Cheng J, Meng J, Zhu L, et al. Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications. Mol Cancer. 2020;19(1):66.
- Zhang X, Zhang Z. Oncohistone Mutations in Diffuse Intrinsic Pontine Glioma. Trends Cancer. 2019;5(12):799–808.
- Ghosh MK, Chakraborty D, Sarkar S, et al. The interrelationship between cerebral ischemic stroke and glioma: a comprehensive study of recent reports. Signal Transduct Target Ther. 2019;4:42.
- Lenting K, Verhaak R, Ter Laan M, et al. Glioma: experimental models and reality. Acta Neuropathol. 2017;133(2):263–282.
- Takacs GP, Flores-Toro JA, Harrison JK. Modulation of the chemokine/chemokine receptor axis as a novel approach for glioma therapy. Pharmacol Ther. 2021;222:107790.
- Dunn GP, Cloughesy TF, Maus MV, et al. Emerging immunotherapies for malignant glioma: from immunogenomics to cell therapy. Neuro Oncol. 2020;22(10):1425–1438.
- DeSouza PA, Qu X, Chen H, et al. Long, Noncoding RNA Dysregulation in Glioblastoma. Cancers (Basel). 2021;13(7):1604. doi:10.3390/cancers13071604.
- Guo CJ, Xu G, Chen LL. Mechanisms of long noncoding rna nuclear retention. Trends Biochem Sci. 2020;45(11):947–960.
- Lin C, Yang L. Long Noncoding RNA in Cancer: wiring Signaling Circuitry. Trends Cell Biol. 2018;28(4):287–301.
- Marchese FP, Raimondi I, Huarte M. The multidimensional mechanisms of long noncoding RNA function. Genome Biol. 2017;18(1):206.
- Sallam T, Sandhu J, Tontonoz P. Long noncoding RNA discovery in cardiovascular disease: decoding Form to Function. Circ Res. 2018;122(1):155–166.
- Alvarez-Dominguez JR, Lodish HF. Emerging mechanisms of long noncoding RNA function during normal and malignant hematopoiesis. Blood. 2017;130(18):1965–1975.
- Jandura A, Krause HM. The New RNA World: growing Evidence for Long Noncoding RNA Functionality. Trends Genet. 2017;33(10):665–676.
- Chen LL. Linking Long Noncoding RNA Localization and Function. Trends Biochem Sci. 2016;41(9):761–772.
- Mazurek M, Litak J, Kamieniak P, et al. Micro RNA Molecules as Modulators of Treatment Resistance, Immune Checkpoints Controllers and Sensitive Biomarkers in Glioblastoma Multiforme. Int J Mol Sci. 2020;21(4):1507. doi:10.3390/ijms21041507.
- Gyoba J, Shan S, Roa W, et al. Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: a Review and Summary of Current Literature. Int J Mol Sci. 2016;17(4):494.
- Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146(3):353–358.
- Ballantyne MD, McDonald RA, Baker AH. lncRNA/MicroRNA interactions in the vasculature. Clin Pharmacol Ther. 2016;99(5):494–501.
- Zhang Y, Jiang X, Wu Z, et al. Long Noncoding RNA LINC00467 Promotes Glioma Progression through Inhibiting P53 Expression via Binding to DNMT1. J Cancer. 2020;11(10):2935–2944.
- Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–W14.
- Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102.
- Vestergaard LK, Oliveira DNP, Poulsen TS, et al. Oncomine Comprehensive Assay v3 vs. Oncomine Comprehensive Assay Plus. Cancers (Basel). 2021;13(20):5230.
- Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(D1):D92–7.
- He Y, Jiang X, Duan L, et al. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway. Mol Cancer. 2021;20(1):156.
- Zhao CX, Yan ZX, Wen JJ, et al. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/beta-catenin axis. Mol Cancer. 2021;20(1):153.
- Yang X, Li X, Zhong C, et al. Circular RNA circPHKA2 Relieves OGD-Induced Human Brain Microvascular Endothelial Cell Injuries through Competitively Binding miR-574-5p to Modulate SOD2. Oxid Med Cell Longev. 2021;2021:3823122.
- Dong X, Chen X, Lu D, et al. LncRNA miR205HG hinders HNRNPA0 translation: anti-oncogenic effects in esophageal carcinoma. Mol Oncol. 2021. DOI:10.1002/1878-0261.13142
- Lu T, Li M, Zhao M, et al. Metformin inhibits human non-small cell lung cancer by regulating AMPK-CEBPB-PDL1 signaling pathway. Cancer Immunol Immunother. 2021. DOI:10.1007/s00262-021-03116-x.
- Cao LL, Guan PP, Zhang SQ, et al. Downregulating expression of OPTN elevates neuroinflammation via AIM2 inflammasome- and RIPK1-activating mechanisms in APP/PS1 transgenic mice. J Neuroinflammation. 2021;18(1):281.
- Zhu S, Tang X, Gao X, et al. hsa_circ_0013401 Accelerates the Growth and Metastasis and Prevents Apoptosis and Autophagy of Neuroblastoma Cells by Sponging miR-195 to Release PAK2. Oxid Med Cell Longev. 2021;2021:9936154.
- Blakeley JO, Coons SJ, Corboy JR, et al. Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations. Neuro Oncol. 2016;18(2):ii13–ii20.
- Deng S, Zhu S, Qiao Y, et al. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma. Protein Cell. 2014;5(12):899–911.
- Li W, Graeber MB. The molecular profile of microglia under the influence of glioma. Neuro Oncol. 2012;14(8):958–978.
- Bohmdorfer G, Wierzbicki AT. Control of Chromatin Structure by Long Noncoding RNA. Trends Cell Biol. 2015;25(10):623–632.
- Kim ED, Sung S. Long noncoding RNA: unveiling hidden layer of gene regulatory networks. Trends Plant Sci. 2012;17(1):16–21.
- Garen A. From a retrovirus infection of mice to a long noncoding RNA that induces proto-oncogene transcription and oncogenesis via an epigenetic transcription switch. Signal Transduct Target Ther. 2016;1(1):16007.
- Zhang Y, Liu Q, Liao Q. Long noncoding RNA: a dazzling dancer in tumor immune microenvironment. J Exp Clin Cancer Res. 2020;39(1):231.
- Cai H, Yu Y, Ni X, et al. LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis. Cell Death Dis. 2020;11(12):1032.
- Mu M, Niu W, Zhang X, et al. LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway. Oncogene. 2020;39(45):6879–6892.
- Zheng J, Wang B, Zheng R, et al. Linc-RA1 inhibits autophagy and promotes radioresistance by preventing H2Bub1/USP44 combination in glioma cells. Cell Death Dis. 2020;11(9):758.
- Dong P, Xiong Y, Konno Y, et al. Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway. J Exp Clin Cancer Res. 2021;40(1):216.
- Zhang X, Li F, Zhou Y, et al. Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer. Cell Death Dis. 2021;12(7):627.
- Yang Z, Ming Y, Wang T, et al. LncRNA SNHG11 promotes the development of colorectal cancer by mediating miR-339-3p/SHOX2. Minerva Med. 2020. DOI:10.23736/S0026-4806.20.06619-7
- Ce W, Luo C, Hotz-Wagenblatt A, et al. Eichmuller SB. miR-339-3p Is a Tumor Suppressor in Melanoma. Cancer Res. 2016;76:3562–3571.